This site is intended for Healthcare professionals only.

Alembic Pharma receives EIR from USFDA


Alembic Pharma receives EIR from USFDA

New Delhi: Drug firm Alembic Pharmaceuticals said it has received Establishment Inspection Report from the US health regulator for its formulation facility located at Panelav in Gujarat.

“The company has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the inspection carried out by them at our formulation facility at Panelav during the period from March 12-20, 2018,” Alembic Pharmaceuticals said in a BSE filing.

USFDA releases a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determines the inspection to be closed.

Read Also: USFDA completes inspection at Alembic Pharma’s Panelav plant



Source: PTI
0 comment(s) on Alembic Pharma receives EIR from USFDA

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted